Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Rice

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Scientific Reports|June 30, 2016
The infectious BAC genomic DNA expression library: a high capacity vector system for functional genomicsMichele M P Lufino, Pauline A H Edser, Michael A Quail, et al.
Health Technology Assessment (Winchester, England)|October 18, 2025
Algorithm-based remote monitoring of heart failure risk data in people with cardiac implantable electronic devices: a systematic review and cost-effectiveness analysisRyan Kenny, Nawaraj Bhattarai, Nicole O'Connor, et al.
Health Technology Assessment (Winchester, England)|April 7, 2016
The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysisEva Kaltenthaler, Christopher Carroll, Daniel Hill-McManus, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 5, 2017
The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal ProcessChristopher Carroll, Eva Kaltenthaler, Daniel Hill-McManus, et al.
Molecular and Cellular Biology|January 30, 2013
The piggyBac transposon displays local and distant reintegration preferences and can cause mutations at noncanonical integration sitesMeng Amy Li, Stephen J Pettitt, Sabine Eckert, et al.
Pharmacoeconomics|October 5, 2023
Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group PerspectiveDiarmuid Coughlan, Oluwatomi Arisa, Katie Thomson, et al.
Pharmacoeconomics|April 29, 2026
Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group PerspectiveJulia Whitehall, Lakshmi Jayachandran, Najmeh Moradi, et al.
European Urology Open Science|July 13, 2023
Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled TrialGe Yu, Stephen Rice, Rakesh Heer, et al.
Emergency Medicine Journal : EMJ|November 11, 2020
Secondary transfer of emergency stroke patients eligible for mechanical thrombectomy by air in rural England: economic evaluation and considerationsDiarmuid Coughlan, Peter McMeekin, Darren Flynn, et al.
Pharmacoeconomics|January 9, 2026
The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group PerspectiveHangjian Wu, Cristina Fernandez-Garcia, Nicole O'Connor, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Scientific Reports|June 30, 2016
The infectious BAC genomic DNA expression library: a high capacity vector system for functional genomicsMichele M P Lufino, Pauline A H Edser, Michael A Quail, et al.
Health Technology Assessment (Winchester, England)|October 18, 2025
Algorithm-based remote monitoring of heart failure risk data in people with cardiac implantable electronic devices: a systematic review and cost-effectiveness analysisRyan Kenny, Nawaraj Bhattarai, Nicole O'Connor, et al.
Health Technology Assessment (Winchester, England)|April 7, 2016
The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysisEva Kaltenthaler, Christopher Carroll, Daniel Hill-McManus, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 5, 2017
The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal ProcessChristopher Carroll, Eva Kaltenthaler, Daniel Hill-McManus, et al.
Molecular and Cellular Biology|January 30, 2013
The piggyBac transposon displays local and distant reintegration preferences and can cause mutations at noncanonical integration sitesMeng Amy Li, Stephen J Pettitt, Sabine Eckert, et al.
Pharmacoeconomics|October 5, 2023
Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group PerspectiveDiarmuid Coughlan, Oluwatomi Arisa, Katie Thomson, et al.
Pharmacoeconomics|April 29, 2026
Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group PerspectiveJulia Whitehall, Lakshmi Jayachandran, Najmeh Moradi, et al.
European Urology Open Science|July 13, 2023
Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled TrialGe Yu, Stephen Rice, Rakesh Heer, et al.
Emergency Medicine Journal : EMJ|November 11, 2020
Secondary transfer of emergency stroke patients eligible for mechanical thrombectomy by air in rural England: economic evaluation and considerationsDiarmuid Coughlan, Peter McMeekin, Darren Flynn, et al.
Pharmacoeconomics|January 9, 2026
The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group PerspectiveHangjian Wu, Cristina Fernandez-Garcia, Nicole O'Connor, et al.
Pageof 10